Raltegravir potassium salt ≥98%, kristalliner Feststoff
Lieferant: Cayman Chemical
|
Gefahr
|
Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM).
It is metabolised primarily by uridine diphosphate glucuronosyltransferase 1A1. Raltegravir has long-term efficacy and safety in managing HIV-1 infection in adults, children, and adolescents.
Formel:
C₂₀H₂₀FKN₆O₅ Lagertemperatur: Kühlschrank |
MDL:
MFCD12031642 CAS-Nummer: 871038-72-1 |
Spezifikation Testergebnisse
Purity | ≥98% |
λmax | 210, 312 nm |
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...